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 RESULTS
 REFERENCES
 METHODS
 ACKNOWLEDGEMENTS
 SUMMARY  AND CONCLUSIONS
An association between male and female sex 
hormones and selenium (Se) status has been reported 
in animals and humans. These relationships may be 
important relative to the use of selenium in hormone 
related diseases such as breast cancer. The purpose 
of this study was to examine the effect of estrogen 
status on the tissue distribution of Se and mRNA 
levels of selenoprotein P (SelP) and glutathione 
peroxidase (GPx) in liver. 60 µCi of 75Se as selenite 
was orally administered to each bilaterally 
ovariectomized rat 5 weeks after implantation with 
either placebo pellet (OVX) or pellet with estradiol 
(OVX+E2). Blood and tissues were collected 1, 3, 6, 
and 24 h after dosing. Differences (P<0.05) in 75Se in 
blood, liver, heart, kidney, spleen, brain, and thymus 
were noted at certain times. Plasma SelP in OVX+E2 
group contained a greater percentage of 75Se at 3, 6 
and 24 h compared to OVX group (P<0.05); 75Se in 
plasma GPx also was greater in OVX+E2 compared 
to OVX group at 24 h (P<0.05). Real-time RT-PCR 
analysis showed that both hepatic SelP mRNA (0.93 
vs. 0.50) and GPx mRNA (2.81 vs. 2.24) were 
significantly greater in OVX+E2 group than in OVX 
group. These results suggest that estrogen status 
affects distribution of ingested Se in tissue- and time-
dependent manners, as well as the expression of 
hepatic SelP and GPx at both protein and mRNA 
level. 
(Supported by the OARDC Grant OHO00201). 
 ABSTRACT
 INTRODUCTION
•Relationships between gender/sex hormones and Se 
status have been observed in animals and humans. 
•Preliminary findings from our laboratory strongly 
support the relationship between estrogen and tissue Se 
status. 
•Insights about impact of estrogen on distribution and 
metabolism of Se in multiple tissues are limited.
•We hypothesize that estrogen status will affect  
metabolism of ingested 75Se-selenite as well as the hepatic 
levels of SelP and GPx mRNA.  
•The objective of this study was to examine the effect of 
estrogen status on tissue distribution and metabolism of  
Se at both mRNA and protein levels in a rat model.
•The results of this study are important when considering 
the use of  Se in the prevention or treatment of hormone-
related diseases such as breast cancer. 
• Behne et al. Biochim Biophys Acta 1990; 1033: 219-25.
• Burk et al.  J. Nutr. 2003; 133: 1517s-1520s.
• Hill et al.  J Biol Chem 2003; 278 : 13640-6.
• Schweizer et al. Biochem J 2005; 386: 221-226. 
• Smith et al.  Nutr Res 1995;15:267-77.
•Estrogen enhances 75Se transport into liver from 1 to 6 hour, and facilitates 75Se   
to extra-hepatic deposition after 6 hour.  
•The decrease in plasma 75Se-SelP from 6 to 24 h suggests that SelP was delivering 
75Se to other tissues.
• Estrogen increased Se content and GPx activity in liver.
•Estrogen up-regulated SelP and GPx mRNA expression in liver.
•Conclusions: Up-regulation of SelP expression in liver has special significance of 
whole-body Se metabolism due to the transport function of SelP. Estrogen appears 
to enhance transport of hepatic Se to selected tissues via increased expression of 
SelP mRNA and subsequent synthesis and excretion of SelP.
The authors gratefully acknowledge support of the Ohio 
Agricultural Research and Development Center (OARDC). 
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Figure 1 75Se activity in tissues at 1, 3, 6, and 24 h after administration 60 μCi 75Se-selenite by gavage. Ovariectomized rats were 
implanted with  either placebo (OVX) or estradiol (OVX+E2). Data are Means ± SEM (n=4 per time in each group). Statistically 
significant differences (P<0.05) between OVX group and OVX+E2 group are denoted by presence of an asterisk (*). Within the 
same treatment (OVX/OVX+E2), means that do not share the same letter are significantly different at P<0.05. Panel A, plasma; 
Panel B, RBC; Panel C, liver; Panel D, brain; Panel E, kidney; Panel F, thymus.  Red line: OVX+E2, Black line: OVX
Figure 3 75Se activity in plasma SelP 1, 3, 6, and 24 h after administration 60 μCi 75Se-selenite by gavage. 
Animals are ovariectomized rats receiving either placebo pellet (OVX) or pellet with estradiol (OVX+E2). 
Data are Mean ± SEM (n=4). Statistically significant difference (P<0.05) between OVX group and 
OVX+E2 group are denoted by presence of an asterisk (*). Within the same treatment (OVX/OVX+E2), 
means do not share the same letter differ significantly (P<0.05).
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Figure 4 Estrogen replacement in OVX rats increases hepatic levels of SelP and GPx1 mRNA. RT reaction 
was carried out with extracted RNA isolated from liver of OVX rats receiving estrogen replacement 
(OVX+E2) and OVX rats with placebo pellet (OVX). Real-time qPCR was performed using an Mx3000P 
QPCR® system. mRNA levels were normalized by GAPDH. Data are Means ± SEM for 6 animals in each 
group. * P<0.05 between OVX and OVX+E2 by Student’s t test 
*
*
1,200
1,400
1,600
1,800
2,000
OVX+E2 OVX D P E M
S
e
 
(
n
g
/
g
)
Figure 2 Effect of estrogen status on hepatic Se concentration (Panel A) and glutathione peroxidase (GPx) activity (Panel B) 
in female SD rats. Test groups include OVX with estrogen replacement (OVX+E2), OVX with placebo replacement (OVX), 
sham-operated with placebo replacement in diestrus (D), proestrus (P), estrus (E), and metestrus (M) stages. Data are Means ±
SEM (n=6). Presence with different letters above each bar indicate significant differ (P<0.05). 
A.  Se concentration B. GPx activity
a
c
bc
ab
bc
c
1,000
1,200
1,400
1,600
1,800
2,000
OVX+E2 OVX D P E M
G
P
x
 
a
c
t
i
v
i
t
y
 
(
U
/
g
 
p
r
o
t
e
i
n
)
a
b b
a
b b
Figure 5 A hypothetical model of estrogen regulation whole-body Se metabolism
